ArticleFrontiers in dental medicine2026
Resistance profiles of fastidious oral anaerobes and other periodontal species by multipoint inoculator: an
Article in Frontiers in dental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Periodontal disease is one of the most prevalent chronic infections worldwide. Associations with systemic conditions, including endocarditis, type 2 diabetes mellitus, cardiovascular disease, and tumor progression, have been extensively investigated in recent studies. Furthermore, it involves pathogens that are often anaerobic, biofilm-associated, and difficult to treat owing to inherent resistance mechanisms and the protective nature of biofilms. As dentists prescribe a substantial proportion of antibiotics and antibiotic resistance is increasing globally, innovative diagnostic methods are urgently needed to ensure effective and sustainable antibiotic stewardship. In this study, anaerobic stock isolates from 30 to 35 frozen samples per genera or species were subjected to minimum inhibitory concentration testing. A multipoint inoculator was used to seed agar plates containing serial antibiotic dilutions, allowing assessment of five commonly used antibiotics: amoxicillin, amoxicillin/clavulanic acid, imipenem, clarithromycin, and levofloxacin. This enabled simultaneous testing of multiple strains under strictly anaerobic conditions, reducing the handling time and material consumption. Among the tested oral pathogens, high resistance levels were observed for clarithromycin. Amoxicillin (±clavulanic acid) remains the most reliable first-line option, whereas levofloxacin may serve as an alternative for certain gram negative anaerobes, when standard treatment protocols are unsuccessful. Mixed-inoculum experiments further showed altered antibiotic responses under biofilm-like conditions. The multipoint inoculator enables reliable testing of oxygen-sensitive anaerobes, including mixed biofilms. Clinical relevance: The presented method enables dental practitioners and laboratories to obtain resistance data from subgingival pathogens, especially in low- and middle-income countries or remote regions where access to centralized microbiology laboratories is limited. This benefits the wider healthcare system by supporting sustainable antibiotic stewardship through reliable, cost-effective resistance testing and the patients by facilitating the selection of an effective targeted agent, particularly in complex cases where multiple empirical antibiotic therapies have failed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.